“…EPS produced by marine microbes have yielded pharmaceutical items, for example, novel anti-inflammatory agents, such as pseudopterosins, topsentins, scytonemin, and manoalide; anticancer agents (e.g., bryostatins, discodermolide, eleutherobin, and sarcodictyin); and anti-microbials (e.g., marinone). The use of probiotic microscopic organisms, i.e., bacteria, for example, lactobacilli and Bifidobacteria, is for the most part in the control of pathogenic microorganisms, through generation of antibacterial protein to be specific, bacteriocin (DeVugst and Vandamme 1994; Kathiresan and Thiruneelakandan 2008) and anticancer substances (Wollowski et al 2001;Meera et al 2011;Yahya et al 2019). The dietary enhancements of lactobacilli are purportedly diminishing the induction of colon cancer (Goldin and Gorbach 1992;Wu and Chen 2006;Selim et al 2018 a).…”